- Home
- MKLY vs FENC Comparison
MKLY vs FENC Comparison
Compare MKLY & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$7.07
Company Overview
Basic Information| Metric | MKLY | FENC |
|---|---|---|
| Founded | 2025 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.7M | 230.8M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | MKLY | FENC |
|---|---|---|
| Price | $10.13 | $7.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $14.50 |
| AVG Volume (30 Days) | 12.6K | ★ 127.6K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $44,642,000.00 |
| Revenue This Year | N/A | $65.12 |
| Revenue Next Year | N/A | $41.08 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.88 | $5.65 |
| 52 Week High | $10.16 | $9.92 |
Technical Indicators
Market Signals| Indicator | MKLY | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 58.77 | 55.71 |
| Support Level | $10.00 | $5.65 |
| Resistance Level | $10.16 | $7.11 |
| Average True Range (ATR) | 0.02 | 0.36 |
| MACD | 0.00 | 0.08 |
| Stochastic Oscillator | 66.67 | 74.59 |
Price Performance
Historical Comparison MKLY
FENC
About MKLY McKinley Acquisition Corporation Class A Ordinary Shares
McKinley Acquisition Corp is a blank check company.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.